Development of a fecal occult blood test using a monoclonal antibody to haptoglobin

Redox Report

Volumn 6, Issue 6, 2001, Pages 363-365

  Xing, P X ^a   Young, G ^b   McKenzie, I F C ^a  

^a AUSTIN RESEARCH INSTITUTE   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HAPTOGLOBIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY FE14.1; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ARTICLE; BODY FLUID; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CARCINOMA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; EFFUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNIZATION; INTERMETHOD COMPARISON; INTESTINE CANCER; MALE; MOUSE; NONHUMAN; OCCULT BLOOD; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SENSITIVITY AND SPECIFICITY; URINE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; CARCINOMA; CHEMISTRY, CLINICAL; COLONIC NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; SENSITIVITY AND SPECIFICITY;

ANIMALIA;

EID: 0035711259     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100001101536544     Document Type: Article

References (7)

1. Evaluation of new occult blood tests for detection of colorectal neoplasia
2. Histological grading of rectal cancer
3. Fecal carcinoembryonic antigen (CEA) in patients with large bowel cancer
4. Identification and characterization of new antigenic fragments related to carcinoembryonic antigen in adult feces
5. Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors
6. Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel
7. Haptoglobin gene expression in human glioblastoma cell lines